These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 37271410)

  • 41. Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells.
    Joshi KK; Phung W; Han G; Yin Y; Kim I; Sandoval W; Carter PJ
    MAbs; 2019 Oct; 11(7):1254-1265. PubMed ID: 31286843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A systematic approach for analysis and characterization of mispairing in bispecific antibodies with asymmetric architecture.
    Wang C; Vemulapalli B; Cao M; Gadre D; Wang J; Hunter A; Wang X; Liu D
    MAbs; 2018; 10(8):1226-1235. PubMed ID: 30153083
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heavy and light chain pairing of bivalent quadroma and knobs-into-holes antibodies analyzed by UHR-ESI-QTOF mass spectrometry.
    Schaefer W; Völger HR; Lorenz S; Imhof-Jung S; Regula JT; Klein C; Mølhøj M
    MAbs; 2016; 8(1):49-55. PubMed ID: 26496506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A new approach to produce IgG
    Zhao C; Zhang W; Gong G; Xie L; Wang MW; Hu Y
    Sci Rep; 2021 Sep; 11(1):18630. PubMed ID: 34545109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Progress in overcoming the chain association issue in bispecific heterodimeric IgG antibodies.
    Klein C; Sustmann C; Thomas M; Stubenrauch K; Croasdale R; Schanzer J; Brinkmann U; Kettenberger H; Regula JT; Schaefer W
    MAbs; 2012; 4(6):653-63. PubMed ID: 22925968
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies.
    Schaefer W; Regula JT; Bähner M; Schanzer J; Croasdale R; Dürr H; Gassner C; Georges G; Kettenberger H; Imhof-Jung S; Schwaiger M; Stubenrauch KG; Sustmann C; Thomas M; Scheuer W; Klein C
    Proc Natl Acad Sci U S A; 2011 Jul; 108(27):11187-92. PubMed ID: 21690412
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Removing half antibody byproduct by Protein A chromatography during the purification of a bispecific antibody.
    Chen X; Wang Y; Li Y
    Protein Expr Purif; 2020 Aug; 172():105635. PubMed ID: 32268171
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An integrated approach for characterizing immunogenic responses toward a bispecific antibody.
    Cohen S; Chung S; Spiess C; Lundin V; Stefanich E; Laing ST; Clark V; Brumm J; Zhou Y; Huang C; Guerrero J; Myneni S; Yadav R; Siradze K; Peng K
    MAbs; 2021; 13(1):1944017. PubMed ID: 34225571
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Leveraging light chain binding avidity for control of mispaired byproducts during production of asymmetric bispecific antibodies.
    Rezvani K; WuDunn D; Hunter AK; Aspelund MT
    J Chromatogr A; 2022 Nov; 1683():463533. PubMed ID: 36195004
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-Molecule 3D Images of "Hole-Hole" IgG1 Homodimers by Individual-Particle Electron Tomography.
    Lei D; Liu J; Liu H; Cleveland TE; Marino JP; Lei M; Ren G
    Sci Rep; 2019 Jun; 9(1):8864. PubMed ID: 31221961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Single variable domain-IgG fusion. A novel recombinant approach to Fc domain-containing bispecific antibodies.
    Shen J; Vil MD; Jimenez X; Iacolina M; Zhang H; Zhu Z
    J Biol Chem; 2006 Apr; 281(16):10706-14. PubMed ID: 16481314
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The eIg technology to generate Ig-like bispecific antibodies.
    Kühl L; Aschmoneit N; Kontermann RE; Seifert O
    MAbs; 2022; 14(1):2063043. PubMed ID: 35427197
    [TBL] [Abstract][Full Text] [Related]  

  • 53. High-Throughput Generation of Bipod (Fab × scFv) Bispecific Antibodies Exploits Differential Chain Expression and Affinity Capture.
    Nesspor TC; Kinealy K; Mazzanti N; Diem MD; Boye K; Hoffman H; Springer C; Sprenkle J; Powers G; Jiang H; La Porte SL; Ganesan R; Singh S; Zwolak A
    Sci Rep; 2020 May; 10(1):7557. PubMed ID: 32372058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization.
    Ridgway JB; Presta LG; Carter P
    Protein Eng; 1996 Jul; 9(7):617-21. PubMed ID: 8844834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cysteine-SILAC Mass Spectrometry Enabling the Identification and Quantitation of Scrambled Interchain Disulfide Bonds: Preservation of Native Heavy-Light Chain Pairing in Bispecific IgGs Generated by Controlled Fab-arm Exchange.
    van den Bremer ETJ; Labrijn AF; van den Boogaard R; Priem P; Scheffler K; Melis JPM; Schuurman J; Parren PWHI; de Jong RN
    Anal Chem; 2017 Oct; 89(20):10873-10882. PubMed ID: 28922593
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EFab domain substitution as a solution to the light-chain pairing problem of bispecific antibodies.
    Cooke HA; Arndt J; Quan C; Shapiro RI; Wen D; Foley S; Vecchi MM; Preyer M
    MAbs; 2018; 10(8):1248-1259. PubMed ID: 30215570
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Culture temperature modulates half antibody and aggregate formation in a Chinese hamster ovary cell line expressing a bispecific antibody.
    Gomez N; Wieczorek A; Lu F; Bruno R; Diaz L; Agrawal NJ; Daris K
    Biotechnol Bioeng; 2018 Dec; 115(12):2930-2940. PubMed ID: 30036451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of Bispecific Antibody Production in Cell Cultures by Unique Mixed Mode Size Exclusion Chromatography.
    Jiang H; Xu W; Liu R; Gupta B; Kilgore B; Du Z; Yang X
    Anal Chem; 2020 Jul; 92(13):9312-9321. PubMed ID: 32497423
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Designing of a bispecific antibody against SARS-CoV-2 spike glycoprotein targeting human entry receptors DPP4 and ACE2.
    Ojha R; Gurjar K; Ratnakar TS; Mishra A; Prajapati VK
    Hum Immunol; 2022 Apr; 83(4):346-355. PubMed ID: 35042653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single-step Protein A and Protein G avidity purification methods to support bispecific antibody discovery and development.
    Ollier R; Wassmann P; Monney T; Ries Fecourt C; Gn S; C A V; Ayoub D; Stutz C; Gudi GS; Blein S
    MAbs; 2019; 11(8):1464-1478. PubMed ID: 31462177
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.